S-8 S-8 EX-FILING FEES 0002022416 Silexion Therapeutics Corp N/A Fees to be Paid 0002022416 2026-05-28 2026-05-28 0002022416 1 2026-05-28 2026-05-28 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-8

Silexion Therapeutics Corp

Table 1: Newly Registered Securities

Security Type

Security Class Title

Fee Calculation Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

1 Equity Ordinary shares, par value $0.0135 per share ("ordinary shares") Other 438,567 $ 0.4205 $ 184,417.42 0.0001381 $ 25.47

Total Offering Amounts:

$ 184,417.42

$ 25.47

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 25.47

Offering Note

1

1. In accordance with Rule 416(a) under the Securities Act of 1933, as amended ("Securities Act"), this registration statement shall also cover any additional ordinary shares as may be offered or issued to prevent dilution resulting from stock splits, stock dividends, or similar transactions pursuant to the terms of the Silexion Therapeutics Corp 2024 Equity Incentive Plan (the "2024 Plan"). 2. Estimated in accordance with Rules 457(c) and 457(h) solely for the purpose of calculating the registration fee on the basis of $0.4205 per share, which represents the average of the high ($0.435) and low ($0.406) prices of the ordinary shares as reported on the Nasdaq Capital Market on May 27, 2026. 3. Represents ordinary shares available for issuance pursuant to potential future grants under the 2024 Plan.

Table 2: Fee Offset Claims and Sources ☑Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rule 457(p)
Fee Offset Claims
Fee Offset Sources